The Push to Monetize Bot Traffic and the FTC’s Data-Sharing Lawsuit
Time magazine has begun serving ads specifically designed for bots—AI-powered agents that crawl the web to answer user questions. The ads appear as FAQ-style brand content, clearly labeled as sponsored, in an attempt to turn growing non-human traffic into a revenue stream. Jonah Goodhart, CEO of AI contextual advertising startup Mobian, remarked that influencing an agent could be even more valuable than influencing a single human, because an agent like ChatGPT can shape results for all its users.
The approach isn’t entirely novel. AI firm Blankspace, founded in late 2025, has integrated with content delivery networks such as Cloudflare and Akamai to serve ads to agents at the exact moment a user queries. A live auction determines which ad the agent sees, and if the agent is persuaded, the advertised product surfaces in what appears to be an organic recommendation—blurring the line between paid and editorial content.
At the same time, the Federal Trade Commission (FTC) filed a lawsuit against telehealth company Hims & Hers, alleging it shared consumers’ sensitive health data—including information about erectile dysfunction and balding treatments—with advertising platforms Meta and Snap without proper consent. The lawsuit also claims the company made it “extremely difficult” for customers to cancel subscriptions. The FTC pointed to the company’s own policy which stated that viewing pages about certain health topics could be passed to advertising partners to deliver targeted ads elsewhere.
In a related development, wellness brand Rosabella is being accused by rival supplement company Humann of using AI-generated videos on TikTok—featuring fake doctors and sensational promises—to sell health supplements with unsubstantiated claims. TikTok, meanwhile, is actively embracing AI-generated video tools, making it simpler for creators and brands to produce clicky, potentially misleading content. These threads hang together: the industry is rapidly expanding its AI-driven advertising arsenal even as regulators probe the misuse of sensitive data and deceptive practices.
What Advertising to AI Agents Means for the Industry and Why the Hims & Hers Case Is a Warning
The Case for Chasing Agent Traffic
The logic behind Time’s bot ads lies in the growing volume of requests originating from AI agents rather than humans. If these agents are already digesting content, feeding them sponsored answers could become a direct line to consumer decisions. Goodhart’s point underscores a structural shift: when one agent conversation can alter the recommendations seen by millions, influencing that agent becomes a scalable lever. Blankspace’s ad auction model essentially applies programmatic principles to a new channel, but it also raises ethical questions—what is an “organic” result if the underlying agent was nudged by a paid placement?
The Regulatory Backlash Over Sensitive Data Sharing
The FTC’s action against Hims & Hers isn’t an isolated incident; it follows a pattern of enforcement against health companies that share identifiable consumer data with ad platforms. Even in a federal climate generally less focused on corporate malfeasance, the agency is signaling that health-data protections remain a priority. The complaint’s twin allegations—unauthorized data sharing and cumbersome cancellation—point to a business model that leaned heavily on advertising tech while failing to respect consumer autonomy. For Meta and Snap, being named as recipients of sensitive health data can sharpen scrutiny on their own data-handling practices and advertiser policies.
AI-Generated Deception Escalates Risks for Platforms
The Rosabella case illustrates another friction point: platforms are equipping creators with AI tools that can easily churn out deceptive ads. TikTok’s push into AI video creation directly lowers the barrier for bad actors. When combined with unverified health claims, the result can be illegal advertising at scale—amplifying the need for automated detection and human oversight that platforms have not yet mastered. This trend adds to the regulatory pressure already simmering around data sharing, painting a picture of an ad ecosystem that is innovating faster than its guardrails.
What Publishers, Health Advertisers, and Platforms Should Do Now
For publishers and ad-tech firms exploring agent-facing inventory, maintaining crystal-clear labeling—as Time does with “sponsored” tags—is crucial to preserve user trust and avoid future regulatory friction. For health and wellness brands that advertise online, the FTC complaint highlights the urgent need to audit third-party data flows, especially integrations with ad platforms like Meta and Snap, and to ensure consent mechanisms meet federal standards; removal of opacity in cancellation processes is also a clear compliance step. For social media platforms and ad networks, the rise of AI-generated content demands proactive verification of health claims and seller identity to prevent their tools from being weaponized for deceptive ads, which could invite their own enforcement actions. Advertisers that rely on programmatic AI visibility should also begin evaluating how their content might be presented to agents, as this intermediary layer could reshape brand perception and performance—starting with a review of how structured data and content are formatted for machine consumption.
Risk & Opportunity Assessment
| Commercial Risk | Medium | Publishers like Time that monetize bot traffic risk alienating human users if the line between sponsored agent content and editorial integrity blurs, potentially reducing long-term audience trust. |
| Competitive Risk | Medium | Agent-targeted ad models such as Blankspace’s could shift ad spend away from traditional search and display ads if proven effective, forcing incumbents to adapt or lose share. |
| Regulatory Risk | High | The FTC’s lawsuit against Hims & Hers shows that sharing sensitive health data with ad platforms without robust consent invites enforcement action, raising the stakes for any company handling health-related consumer data. |
| Reputation Risk | High | Hims & Hers faces direct reputational damage from allegations of mishandling health data and obstructing cancellations; for platforms like Meta and Snap, being tied to such data sharing could draw consumer and regulatory criticism. |
| Technology Disruption | Transformational | The emergence of advertising that targets AI agents rather than end users could fundamentally alter how digital marketing channels operate, effectively creating a new layer of intermediation between brands and consumers. |
| Commercial Opportunity | High | Early movers in agentic advertising, such as Blankspace and publishers experimenting with bot-facing formats, stand to capture a nascent revenue stream as AI agent traffic continues to grow and as programmatic principles extend to machine-to-machine communications. |
Comments 0